CELU (Celularity Inc. Class A Common Stock) Stock Analysis - SEC Filings

Celularity Inc. Class A Common Stock (CELU) is a publicly traded Healthcare sector company. As of May 21, 2026, CELU trades at $0.83 with a market cap of $23.11M and a P/E ratio of -0.31. CELU moved +4.21% today. Year to date, CELU is -34.51%; over the trailing twelve months it is -64.58%. Its 52-week range spans $0.71 to $5.22. Rallies surfaces CELU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find CELU SEC filings?

Rallies organizes CELU SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

CELU Key Metrics

Key financial metrics for CELU
MetricValue
Price$0.83
Market Cap$23.11M
P/E Ratio-0.31
EPS$-2.64
Dividend Yield0.00%
52-Week High$5.22
52-Week Low$0.71
Volume0
Avg Volume0
Revenue (TTM)$54.22M
Net Income$-57.89M
Gross Margin72.36%

Latest CELU News

CELU Analyst Consensus

CELU analyst coverage data. Average price target: $0.00.

Common questions about CELU

Where can I find CELU SEC filings?
Rallies organizes CELU SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show CELU 10-K and 10-Q filings?
Rallies organizes CELU SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is CELU research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CELU. It does not provide personalized investment advice.
CELU

CELU